Chemical Compound
Dehydroepiandrosterone 3-glucuronide
CAS Registry Number
5716-14-3
Primary Record
Dehydroepiandrosterone 3-glucuronide
Note: Only for scientific research or as raw materials for production.
- In stock
- 7,916 g
- Purity
- 99.4 %
- CAS
- 5716-14-3
Compound Identifiers & Properties
- CAS
- 5716-14-3
- PubChem CID
- 470824
- SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O)C
- Canonical SMILES
- C[C@]12CC[C@H](O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12
Names & Synonyms
- Dehydroepiandrosterone 3-glucuronide
- AC1LALUU
- DHEA-G
- RefChem:131504
- Dehydroisoandrosterone 3-glucuronide
- CHEMBL2074982
- SCHEMBL7529699
- CHEBI:68834
- CTK7I3644
- Dehydroepiandrosterone Glucuronide
- DTXCID40359286
- DTXSID30408434
- Dehydroepiandrosterone 3-glucuronoside
- Dehydroepiandrosterone3-glucuronide
- AIDS070518
- BDBM50420254
- CID470824
- Dehydroepiandrosterone 3?-Glucuronide
- Dehydroepiandrosterone glucopyranuronoside
- LMST05010045
- CS-I-00073
- dehydroepiandrosterone 3-beta-d-glucuronide
- Dehydroepiandrosterone 3-beta-glucuronide
- dehydroisoandrosterone glucopyranuronoside
- Dehydroisoandrosterone 3-glucuronidecrys talline
- J709.891J
- 3-(glucuronide)-(3-beta)-androst-5-en-17-one
- 5716-14-3
- Q27137208
- 3BETA-HYDROXY-5-ANDROSTEN-17-ONE 3-GLUCURONIDE
- Androst-5-en-17-one, 3-(glucuronide)-, (3.beta.)-
- 3beta-(beta-D-Glucopyranuronosyloxy)androsta-5-ene-17-one
- (2S,3S,4S,5R,6R)-6-[[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
- 17-Oxoandrost-5-en-3beta-yl beta-D-glucopyranosiduronic acid
- 3331-64-4
- (3beta)-17-oxoandrost-5-en-3-yl beta-D-glucopyranosiduronic acid
- (2s,3s,4s,5r,6r)-6-[[(3s,8r,9s,10r,13s,14s)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid
- (2S,3S,4S,5R,6R)-6-(((3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta(a)phenanthren-3-yl)oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
- (2S,3S,4S,5R,6R)-6-{[(3aS,3bR,7S,9aR,9bS,11aS)-9a,11a-dimethyl-1-oxo-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
- (3S,4S,5R,6R)-6-((10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta(a)phenanthren-3-yl)oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
- (3S,4S,5R,6R)-6-((2,15-dimethyl-14-oxotetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-7-en-5-yl)oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
- (3S,4S,5R,6R)-6-({2,15-dimethyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
- (3S,4S,5R,6R)-6-[(10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
- na